BioSig Technologies, Inc.

For the period ended Jun 30, 2025. Filed Aug 15, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 15, 2025

STEX$0.34+4.1%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	BIOSIG TECHNOLOGIES, INC.
Date: August 15, 2025	By:	/s/ Henry McPhie
		Henry McPhie
		Chief Executive Officer (Principal Executive Officer)
Date: August 15, 2025	By:	/s/ Ferdinand Groenewald
		Ferdinand Groenewald
		Acting Chief Financial Officer (Principal Accounting Officer)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.